Parainfluenza
Information
- Disease name
- Parainfluenza
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00641017 | Completed | Phase 1 | Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine | March 2008 | July 2012 |
| NCT01644877 | Completed | Phase 2 | A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen | March 2014 | December 15, 2016 |
| NCT01924793 | Completed | Phase 2 | An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection | August 2013 | May 2017 |
| NCT02984280 | Completed | Specific Respiratory Infections as Triggers of Acute Medical Events | September 2016 | March 2017 | |
| NCT03808922 | Recruiting | Phase 3 | Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study | May 23, 2019 | December 31, 2024 |
| NCT00186927 | Suspended | Phase 1 | A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and Toddlers | May 5, 2005 | January 2026 |